Regulation of T helper cell differentiation by integrated STAT and Ikaros zinc finger transcription factor mechanisms

通过整合 STAT 和 Ikaros 锌指转录因子机制调节 T 辅助细胞分化

基本信息

项目摘要

PROJECT SUMMARY In order to coordinate pathogen-specific immune responses, CD4+ T helper cells must differentiate into distinct effector subtypes, including TH1, TH2, TH17, and T follicular helper (TFH) cells. T helper cell subtype differentiation is regulated at the gene expression level and occurs in response to cell-extrinsic cytokine signals. The prevailing model in the field has been that unique, lineage-defining transcription factors are activated in precursor cells by cytokine signaling and are largely responsible for establishing the cell-type specific gene expression profiles that promote T helper cell differentiation. For example, the lineage-defining transcription factor Bcl-6 has been described as as the “master regulator” of TFH cell development. While the importance of factors like Bcl-6 is unquestioned, the notion of singular factors dictating T helper differentiation has been challenged by findings demonstrating that the differentiation of each T helper subset requires the concerted action of complex, cytokine-driven transcriptional networks, rather than the function of an individual transcription factor. The identification of the proteins that comprise these networks and the molecular mechanisms they utilize to promote cell-specific gene expression patterns will significantly advance our understanding of the regulation of T helper cell differentiation, and establish a scientific basis for the rational design of novel, increasingly effective immunotherapies. The long-term goal of our research program is to elucidate the transcriptional networks that regulate T helper cell differentiation and define the mechanisms by which subtype-specific gene expression patterns are regulated. In this application, we are focusing on the role of two notable transcription factor families: Signal Transducer and Activator of Transcription (STAT) and Ikaros Zinc Finger (IkZF) factors. Exciting preliminary data from our lab indicates that the IkZF factor Aiolos cooperates with STAT3 to induce the expression of Bcl-6. Mechanistically, a shared cytokine environment allows for increased Aiolos expression, STAT3 activation, and the formation of an Aiolos/STAT3 complex that associates with the Bcl6 promoter. Collectively, these findings provide the scientific premise for the work in this application and suggest that the interplay between these members of the STAT and IkZF transcription factor families represents a novel regulatory mechanism that promotes Bcl-6 expression and perhaps TFH cell development. Because IkZF and STAT family members are highly conserved, we propose the conceptually innovative hypothesis that the differentiation of distinct T helper subsets, including that of TFH cells, is dependent upon the formation and activity of subtype-specific IkZF/STAT complexes. We will test this hypothesis by i) elucidating the coordinated mechanisms by which Aiolos and STAT3 activate Bcl-6 expression, ii) defining the role of Aiolos/STAT3 complexes in TFH differentiation, and iii) determining whether conserved IkZF/STAT interactions regulate additional T helper cell gene programs.
项目摘要 为了协调病原体特异性免疫应答,CD4 + T辅助细胞必须分化成不同的免疫应答。 效应子亚型,包括TH1、TH2、TH17和T滤泡辅助(TFH)细胞。辅助性T细胞亚型 分化在基因表达水平上受到调节,并响应于细胞外源性细胞因子而发生 信号.该领域的流行模型是,独特的、谱系定义的转录因子是 在前体细胞中通过细胞因子信号传导被激活,并且主要负责建立细胞类型 促进T辅助细胞分化的特异性基因表达谱。例如,血统定义 转录因子Bcl-6被描述为TFH细胞发育的"主调节因子"。而 Bcl-6等因子的重要性是毋庸置疑的,单一因子决定T辅助细胞分化的概念 已经受到挑战的发现表明,每个辅助性T细胞亚群的分化需要 复杂的、由基因驱动的转录网络的协同作用,而不是个体的功能。 转录因子识别构成这些网络的蛋白质和分子生物学特征, 他们用来促进细胞特异性基因表达模式的机制将显著促进我们的研究。 了解辅助性T细胞分化的调节,并为合理的治疗建立科学依据 设计新颖的、越来越有效的免疫疗法。 我们研究计划的长期目标是阐明调节T细胞的转录网络。 辅助细胞分化,并确定亚型特异性基因表达模式的机制, 监管.在本申请中,我们关注两个显著的转录因子家族的作用: 转录转导和激活因子(STAT)和Ikaros锌指(IkZF)因子。令人兴奋的初步 来自我们实验室的数据表明,IkZF因子Aiolos与STAT 3合作,诱导 Bcl-6从机制上讲,共享的细胞因子环境允许增加的Aiolos表达,STAT3激活, 以及与Bcl 6启动子相关的Aiolos/STAT 3复合物的形成。总的来说,这些 研究结果提供了科学的前提下,在这项工作中的应用,并建议, STAT和IkZF转录因子家族的这些成员代表了一种新的调节机制 促进Bcl-6表达和TFH细胞发育。因为IkZF和STAT家族成员 是高度保守的,我们提出了概念上的创新假设,即不同的T细胞的分化 包括TFH细胞在内的辅助细胞亚群依赖于亚型特异性的 IkZF/STAT复合物。我们将通过以下方式检验这一假设:i)阐明协调机制, Aiolos和STAT3激活Bcl-6表达,ii)定义Aiolos/STAT3复合物在TFH分化中的作用, 和iii)确定保守的IkZF/STAT相互作用是否调节额外的T辅助细胞基因程序。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Additive manufacturing of three-dimensional (3D) microfluidic-based microelectromechanical systems (MEMS) for acoustofluidic applications.
  • DOI:
    10.1039/c8lc00427g
  • 发表时间:
    2018-07-10
  • 期刊:
  • 影响因子:
    6.1
  • 作者:
    Cesewski E;Haring AP;Tong Y;Singh M;Thakur R;Laheri S;Read KA;Powell MD;Oestreich KJ;Johnson BN
  • 通讯作者:
    Johnson BN
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kenneth Joseph Oestreich其他文献

Kenneth Joseph Oestreich的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kenneth Joseph Oestreich', 18)}}的其他基金

Identifying novel regulatory pathways underlying T helper 1 cell immune responses
识别 T 辅助细胞 1 细胞免疫反应的新调控途径
  • 批准号:
    10377575
  • 财政年份:
    2018
  • 资助金额:
    $ 26.25万
  • 项目类别:
Identifying novel regulatory pathways underlying T helper 1 cell immune responses
识别 T 辅助细胞 1 细胞免疫反应的新调控途径
  • 批准号:
    9914202
  • 财政年份:
    2018
  • 资助金额:
    $ 26.25万
  • 项目类别:
Identifying novel regulatory pathways underlying T helper 1 cell immune responses
识别 T 辅助细胞 1 细胞免疫反应的新调控途径
  • 批准号:
    10132970
  • 财政年份:
    2018
  • 资助金额:
    $ 26.25万
  • 项目类别:
Identifying novel regulatory pathways underlying T helper 1 cell immune responses
识别 T 辅助细胞 1 细胞免疫反应的新调控途径
  • 批准号:
    10001826
  • 财政年份:
    2018
  • 资助金额:
    $ 26.25万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.25万
  • 项目类别:
    Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
    Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
    Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 26.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了